| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |